Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 8, 2015
Boston Scientific Corporation (NYSE: BSX) hat die angekündigte Vereinbarung mit Endo International plc (NASDAQ: ENDP) (TSX: ENL) zur Übernahme der Bereiche Men’s Health und Prostate Health von...
-
Mar 19, 2015Innovative device offers first-line treatment for patients at risk of sudden cardiac arrest
Boston Scientific Corporation (NYSE: BSX) has received FDA and CE Mark approval of the EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) System. The EMBLEM S-ICD System is a treatment...
-
Mar 13, 2015First-Of-Its-Kind Alternative to Long-Term Warfarin Therapy for Stroke Risk Reduction in Patients with Non-Valvular Atrial Fibrillation
Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the WATCHMAN Left Atrial Appendage Closure Device. The WATCHMAN Device offers a new...
-
Mar 13, 2015Un dispositivo innovador que ofrece una alternativa al tratamiento con warfarina a largo plazo para reducir el riesgo de ictus en los pacientes con fibrilación auricular no valvular.
Boston Scientific Corporation (NYSE: BSX) ha recibido la aprobación de su dispositivo WATCHMAN para el cierre de la orejuela auricular izquierda por parte de la Administración de alimentos y...
-
Oct 16, 2014The innovative devices allow pacemaker patients access to full body MRI scans in 1.5 Tesla and 3.0 Tesla systems
Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for the ACCOLADETM pacemaker family. When implanted with the company's INGEVITYTM leads, ACCOLADE pacemakers are the first...